The high expression of DMBT1 in liver-metastatic tumor cells but not in normal liver or bone marrow-derived cells58 indicates a strategy to inhibit tumor–KC interaction by targeting DMBT1 for metastasis treatment. This evidence concerns the gene CALCA and neoplasm.